Huonslab has submitted the Biologics License Application for Recombinant Human Hyaluronidase ‘HY... 신민준 2025.12.25 오후 03:40 Huons USA to participate in CHPI Americas, a leading pharma event held in the U.S. 신민준 2025.05.28 오후 09:09 Huonslab Shares HLB3-002 Formulation Study Results at 2025 AACR 송영두 2025.04.30 오전 10:09 China Market Boosts Daehwa's Outlook, Targeting W200b[K-Bio Pulse] 유진희 2025.03.12 오전 07:56 Huonslab's HyDIFFUZE Abstract Selected for Presentation at AACR 2025 신민준 2025.04.04 오전 09:03 PanGen Biotech Reports Q2 2025 Financial Results with 3.49 Billion won in Revenue and 833 million... 신민준 2025.08.13 오후 06:34 Huonslab presents its remarkable formulation conversion technology at BIO USA 신민준 2025.06.17 오후 07:00 Huons Global reports Q1 sales of 199.1 billion won, operating profit of 25.6 billion won 신민준 2025.05.15 오후 08:20 Rokit Healthcare Soars on U.S. Medical Approval; Huons, Sears Rally[K-Bio Pulse] 송영두 2025.10.17 오전 07:40 로딩중..
Huonslab
Huonslab
![China Market Boosts Daehwa's Outlook, Targeting W200b[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25031200308b.jpg)
![Rokit Healthcare Soars on U.S. Medical Approval; Huons, Sears Rally[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/10/PS25101700177b.jpg)